









UZH -
Institute for Regenerative Medicine • IREM














Home

Main navigation

Search

Jump to content




Breadcrumb


University of Zurich


Institute for Regenerative Medicine • IREM



Organization

Research

Clinical Centers

Bench to Bedside

Teaching

News

Calendar of Events

Contact











Seitenfunktionen



Druckansicht



Schrift grösser/kleiner




Service Navigation



Home


Contact



Sitemap















University of Zurich









Institute for Regenerative Medicine • IREM



Main navigation


Institute for Regenerative Medicine • IREM




Subpages


Organization

Research

Clinical Centers

Bench to Bedside

Teaching

News

Calendar of Events

Contact















IREM News






Biogen Reports New Data from Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab







Aducanumab Alzheimer-Therapiestudie Biogen EMERGE

Aducanumab (BIIB037)

Studie zur Wirksamkeit und Sicherheit von Aducanumab (BIIB037) bei Alzheimer-Krankheit im Frühstadium.





Weitere Informationen






Clinical Studies / Klinische Studien




Clinical Centers / Klinische Zentren



Clinical Studies / Klinische Studien



Become a subject / Werden Sie Studienteilnehmer
















Cell-based Regeneration & Organoid Technologies

Simon P. Hoerstrup, MD, PhD










Biomarkers / Imaging

Christoph Hock, MD












Antibody-based Regeneration

Roger M. Nitsch, MD










Cell- and Systems Biology

Lawrence Rajendran, PhD












Clinical Centers












BioEntrepreneurship and Innovation



















Fusszeile


top



Home

Contact

Sitemap

© University of Zurich

22 Aug 2017


Data Protection Statement







